RxDoctor Payments Data

Sarah Martinez, PA

Physician Assistant · Mooresville, NCNPI 1023778776

Payments from drug & device makers

$11,002in general payments, 2019–2025

Across 580 payments — averaging $18.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$1K
  • EMD Serono, Inc.$1K
  • TG Therapeutics, Inc.$887
  • Neurelis, Inc.$546
  • UCB, Inc.$491
  • plus $5K from 45 others

What the payments were for

  • Speaking & faculty fees$230%
  • Food & beverage$10,90099%
  • Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,002 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$303,203
Medicare patients
163
Services billed
25,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GilenyaFingolimod Hcl26$294,670
Kesimpta PenOfatumumab17$209,407
RebifInterferon Beta-1a/Albumin12$126,215
ZeposiaOzanimod Hydrochloride14$125,971
CopaxoneGlatiramer Acetate14$81,648
NuedextaDextromethorphan Hbr/Quinidine48$77,234
GlatopaGlatiramer Acetate21$73,444
LinzessLinaclotide24$15,409
Emgality PenGalcanezumab-Gnlm11$12,362
Aimovig AutoinjectorErenumab-Aooe15$11,007
Xtampza ErOxycodone Myristate14$10,895
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine232$8,337
Dalfampridine ErDalfampridine27$6,268
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen201$5,655
AdlarityDonepezil Hcl11$5,622

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisGilenya$1,194$294,67026 claims
EMD Serono, Inc.Rebif$1,191$126,21512 claims
Teva Pharmaceuticals USA, Inc.Copaxone$461$81,64814 claims
Avanir Pharmaceuticals, Inc.Nuedexta$32$77,23448 claims
SandozGlatopa$50$73,44421 claims
AbbVieLinzess$1,404$15,40924 claims
Corium, LLCAdlarity$19$5,62211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →